Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1

Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study63% of participants taking tirzepatide 15 mg achieved at le...

Related Keywords

Mexico ,Taiwan ,Japan ,United States ,India ,Argentina ,Brazil ,China ,Dabom ,Arunachal Pradesh ,Russia ,Maggie Pfeiffer ,Prnewswire Tirzepatide ,Kevin Hern ,Eli Lilly ,Jeff Emmick ,Louisj Aronne ,Instagram ,Linkedin ,Twitter ,Presbyterian Weill Cornell Medical Center ,Exchange Commission ,Facebook ,Weight Control Center ,Comprehensive Weight Control Center ,Metabolic Research ,Weill Cornell Medicine ,Weill Cornell Medical Center ,Cautionary Statement Regarding Forward Looking ,Private Securities Litigation Reform Act ,United States Securities ,